Oncology Pharma (OTCMKTS:ONPH) Shares Cross Above Fifty Day Moving Average – Here’s Why

Oncology Pharma Inc. (OTCMKTS:ONPH – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.04 and traded as high as $0.0405. Oncology Pharma shares last traded at $0.0405, with a volume of 9,604 shares.

Oncology Pharma Trading Down 8.6%

The company has a fifty day moving average of $0.04 and a 200 day moving average of $0.05.

About Oncology Pharma

(Get Free Report)

Oncology Pharma, Inc. is a biopharmaceutical company focused on developing treatments for cancer. Its business centers on oncology drug development rather than a portfolio of marketed medicines. The company has worked on Nano-Cycl, an investigational nanoparticle-based formulation involving cyclodextrin for potential use in cancer treatment. The candidate remains a development effort, not an established commercial product. Publicly available information about Oncology Pharma’s leadership, operating history and geographic reach is limited, so those details are not included here.

Further Reading

Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.